poster

Use of the EM algorithm in population pharmacokinetic analysis

Thursday 16 October, 2025

Sparse data arising from a population pharmacokinetic study can be analyzed by nonlinear mixed effects models. The most widely used…

Read more

Estimation of Population Pharmacokinetic Parameters of Tobramycin in Intensive Care Unit Patients Using Different Programs

Thursday 16 October, 2025

Aminoglycoside (AMG) antibiotics are used in prophylaxis and treatment of serious infections in the intensive care units (ICU). Many physicians…

Read more

Evaluation Of Bayesian Estimators For Adaptative Control Of Vancomycin Built With Two Methods Of Population Modeling

Thursday 16 October, 2025

The aim of this study is to constitute two Bayesian estimators. For adaptative control of Vancomycin from the same population…

Read more

Population pharmacokinetics of nortriptyline at monotherapy and during concomitant treatment with drugs that inhibit CYP2D6; an evaluation with the nonparametric maximum likelihood method

Thursday 16 October, 2025

Therapeutic drug monitoring data of nortriptyline (NT) were evaluated with the nonparametric maximum likelihood method (NPML) in order to determine…

Read more

Non-Parametric Density Estimation Applied To Population Studies

Thursday 16 October, 2025

The aim of a population Study [1] is to describe the variability and to detect particular subsets by establishing the…

Read more

Information Theory in Drug Development. Applications to a new antidepressant.

Thursday 16 October, 2025

The aim of the study was to assess the inter-individual variability of F2207, a new antidepressant drug with an original…

Read more

Cyclosporine Population Pharmacokinetic Parameters In The Early Postoperative Hepatic Transplantation Phase: Preliminary Results

Thursday 16 October, 2025

Objective: The purpose of the present study was to estimate the variability of cyclosporine pharmacokinetic parameters (slope of volume to…

Read more

Covariate Identification for Population Pharmacokinetic Modelling

Thursday 16 October, 2025

Explaining and quantifying the variability in response to drugs is an important step in producing efficacious and safe dosage regimens….

Read more

Population analysis of a dose ranging study

Thursday 16 October, 2025

In an important paper Sheiner et al discussed clinical trials design for dose ranging studies. It is the aim of this…

Read more

Pharmacokinetics of Meropenem in pediatrics – NONMEM analysis

Thursday 16 October, 2025

Introduction: Meropenem is a broad spectrum carbapenem antibiotic which is likely to be useful in children. Aims: To estimate population…

Read more